Cristina Fernández's research while affiliated with University of Illinois at Chicago and other places

Publication (1)

Article
The development, activity, pharmacokinetics, pharmacodynamics, clinical efficacy, adverse effects, and dosage and administration of daptomycin are reviewed. Daptomycin, a novel cyclic lipopeptide antimicrobial, is bactericidal against a range of gram-positive bacteria, including many multiple-drug-resistant isolates. It has only minimal activity ag...

Citations

... In this context, methicillin-resistant S. aureus (MRSA) infections with reduced susceptibility to glycopeptide antibiotics, specifically vancomycin (VAN), have become more frequently identified [4,5]. To mitigate this problem, the use of daptomycin (DAP) amid VAN resistance has become a viable option over the past decade [6]. ...